z-logo
Premium
Opposite effects of CCK B agonists in grooming behaviour in rats: further evidence for two CCK B subsites
Author(s) -
Ladurelle Nathalie,
Sebret Angélique,
Garbay Christiane,
Roques Bernard P.,
Daugé Valérie
Publication year - 1998
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0701933
Subject(s) - agonist , receptor , medicine , chemistry , endocrinology , sulpiride , sch 23390 , antagonism , antagonist , receptor antagonist , partial agonist , dopaminergic , pharmacology , biology , dopamine
1 The hypothesis of the existence of two CCK B receptor subsites, CCK B1 and CCK B2 corresponding probably to different coupling states of CCK B receptors, was studied by measuring grooming behaviour in rats. 2 The B1 receptor agonist, BC197 (300 μg kg −1 , i.p.) produced a 45–50% decrease in grooming activity, which was prevented by both the CCK B receptor antagonists CI‐988 (20 μg kg −1 i.p.) and L‐365,260 (200 μg kg −1 , i.p.). 3 In contrast, 3, 10 and 30 μg kg −1 , i.p., of the potent B2 receptor agonist, BC264, enhanced grooming (150–190%). This effect was prevented by previous injection of 75 μg kg −1 of L‐365,260 while higher doses (200 μg kg −1 , i.p.) produced only a partial antagonism. Moreover, CI‐988 (20 μg kg −1 , i.p.), showed an opposite effect in potentiating the responses induced by BC264. However, 200 μg kg −1 of CI‐988 tended to suppress the increase of grooming induced by BC264. 4 The effects of BC264 were prevented by the D 1 receptor (SCH 23390) and D 2 receptor (sulpiride) antagonists, while those of BC197 were only antagonized by sulpiride, emphasizing the existence of a link between peptidergic (CCK) and dopaminergic systems. 5 This study brings additional evidence for the existence of the two CCK B receptor subsites and suggests that particular attention should be focused on the selectivity of CCK B receptor agonists, notably to explain the fact that some compounds such as Boc‐CCK4 induce anxiogenic‐like effects while others, including BC264, are devoid of these effects.British Journal of Pharmacology (1998) 124 , 1091–1098; doi: 10.1038/sj.bjp.0701933

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom